Clinical Trials
35 trialsPOEMA
argenx
MG-ARCADIA
AstraZeneca
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
AstraZeneca
MyaRESP
Institut de Myologie, France
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
argenx
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Alexion Pharmaceuticals, Inc.
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Alexion Pharmaceuticals, Inc.
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
argenx
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
argenx
EARLY-MG
Centre Hospitalier Universitaire de Nice
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
TREAT-OMG
Tang-Du Hospital
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
Centre Hospitalier Universitaire de Nice
The EXPLORE MG Registry for Myasthenia Gravis
Yale University
CAPTURE - MG
Leiden University Medical Center
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Huashan Hospital
OPTIMISE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
VRMG
Vitaccess Ltd
CoRDS
Sanford Health
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
Huashan Hospital
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
University of California, San Francisco
NAD-AIRE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
ZS Associates
Biomarkers in Autoimmune Disease of Nervous System
Tongji Hospital
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
INFORM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis
Jagiellonian University
MGFAPR
Myasthenia Gravis Foundation of America
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Assiut University
POWER-MG
Heinrich-Heine University, Duesseldorf
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Myasthenia Gravis Registry in China
Huashan Hospital
A Prospective Cohort Study of Myasthenia Gravis in China
Peking Union Medical College Hospital
Study of Myasthenic Crisis in China
Huashan Hospital